Indivior Pharmaceuticals (INDV) Cash from Operations (2024 - 2026)

Indivior Pharmaceuticals' Cash from Operations history runs 3 years deep, the most recent figure standing at 9000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 112.0% year-over-year to 9000000.0; the TTM figure through Mar 2026 stood at 111000000.0 (down 175.0% YoY), while the FY2025 annual figure was 27000000.0, down 175.0% from the prior year.
• Cash from Operations was 9000000.0 for Q1 2026 at Indivior Pharmaceuticals, up from 221000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 158000000.0 in Q2 2025 to a low of 221000000.0 in Q4 2025.
• Historically, Cash from Operations has averaged 0.0 across 3 years, with a median of 9000000.0 in 2026.
• Biggest YoY gain for Cash from Operations was 302.7% in 2025; the steepest drop was 2050.0% in 2025.
• A 3-year view of Cash from Operations shows it stood at 17000000.0 in 2024, then sank by 1200.0% to 221000000.0 in 2025, then soared by 95.93% to 9000000.0 in 2026.
• The last three Cash from Operations figures came in at 9000000.0 (Q1 2026), 221000000.0 (Q4 2025), and 39000000.0 (Q3 2025), per Business Quant data.